Skip to main content
Journal of Genetic Engineering and Biotechnology
Fig. 2 | Journal of Genetic Engineering and Biotechnology

Fig. 2

From: IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

Fig. 2

Zinc administration improve liver stiffness (decrease fibrosis grade). Zinc administration during treatment with both A SOF/RBV and B SOF/RBV + Peg-INF improve fibrosis in HCV patients. Fibrosis improvement was more noticeable in patients with CC genotype than T allele carriers. IL-28B rs12979860 single-nucleotide polymorphism genotypes. T allele carriers = CT/TT combined

Back to article page